{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:47:33Z","timestamp":1787870853536,"version":"build-2784847793"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"CIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008270","name":"Lantheus Medical Imaging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008270","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.rmed.2025.108126","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:15:09Z","timestamp":1746058509000},"page":"108126","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: A prospective cohort study"],"prefix":"10.1016","volume":"243","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0751-2995","authenticated-orcid":false,"given":"Pouria","family":"Alipour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo B.","family":"Nery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob S.","family":"Beanlands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Wiefels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anahita","family":"Tavoosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Boczar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"De Bortoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Birnie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2025.108126_bib1","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1055\/s-0040-1712535","article-title":"Cardiac sarcoidosis","volume":"41","author":"Birnie","year":"2020","journal-title":"Semin. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108126_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.acvd.2016.12.014","article-title":"Cardiac sarcoidosis: diagnosis, therapeutic management and prognostic factors","volume":"110","author":"Chapelon-Abric","year":"2017","journal-title":"Arch Cardiovasc Dis"},{"key":"10.1016\/j.rmed.2025.108126_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00991-2017","article-title":"Phenotypes of organ involvement in sarcoidosis","volume":"51","author":"Schupp","year":"2018","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108126_bib4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021183","article-title":"Corticosteroid and immunosuppressant therapy for cardiac sarcoidosis: a systematic review","volume":"10","author":"Fazelpour","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2025.108126_bib5","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1253\/circj.CJ-19-0508","article-title":"JCS 2016 guideline on diagnosis and treatment of cardiac sarcoidosis - digest version","volume":"83","author":"Terasaki","year":"2019","journal-title":"Circ. J."},{"key":"10.1016\/j.rmed.2025.108126_bib6","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0145-2019","article-title":"Clinical phenotyping: role in treatment decisions in sarcoidosis","volume":"29","author":"Baughman","year":"2020","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2025.108126_bib7","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108126_bib8","article-title":"Investigating the treatment phenotypes of cardiac sarcoidosis: a prospective cohort study","volume":"24","author":"Wiefels","year":"2022","journal-title":"Am. Heart J."},{"key":"10.1016\/j.rmed.2025.108126_bib9","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1007\/s12350-017-0978-9","article-title":"Joint SNMMI-ASNC expert consensus document on the role of (18)F-FDG PET\/CT in cardiac sarcoid detection and therapy monitoring","volume":"24","author":"Chareonthaitawee","year":"2017","journal-title":"J. Nucl. Cardiol. : official publication of the American Society of Nuclear Cardiology"},{"key":"10.1016\/j.rmed.2025.108126_bib10","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.ahj.2019.10.003","article-title":"Cardiac Sarcoidosis multi-center randomized controlled trial (CHASM CS- RCT)","volume":"220","author":"Birnie","year":"2020","journal-title":"Am. Heart J."},{"key":"10.1016\/j.rmed.2025.108126_bib11","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ijcard.2016.11.142","article-title":"Serial FDG-PET scans help to identify steroid resistance in cardiac sarcoidosis","volume":"228","author":"Shelke","year":"2017","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.rmed.2025.108126_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107063","article-title":"Why doesn't anyone want to cure sarcoidosis?: the neglect of disease termination","volume":"213","author":"Judson","year":"2023","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108126_bib13","first-page":"56","article-title":"Defining the clinical outcome status (COS) in sarcoidosis: results of WASOG Task Force","volume":"28","author":"Baughman","year":"2011","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2025.108126_bib14","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1378\/chest.111.3.623","article-title":"Outcome in sarcoidosis. The relationship of relapse to corticosteroid therapy","volume":"111","author":"Gottlieb","year":"1997","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108126_bib15","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1164\/ajrccm.149.4.8143052","article-title":"Outcome of the treatment for sarcoidosis","volume":"149","author":"Hunninghake","year":"1994","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2025.108126_bib16","first-page":"173","article-title":"The longitudinal study of chronic sarcoidosis","volume":"94","author":"Johns","year":"1983","journal-title":"Trans. Am. Clin. Climatol. Assoc."},{"key":"10.1016\/j.rmed.2025.108126_bib17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1378\/chest.121.1.24","article-title":"Early treatment of stage II sarcoidosis improves 5-year pulmonary function","volume":"121","author":"Pietinalho","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2025.108126_bib18","first-page":"52","article-title":"The late follow-up of chronic sarcoid patients previously treated with corticosteroids","volume":"15","author":"Rizzato","year":"1998","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2025.108126_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/diagnostics11071289","article-title":"Efficacy and tolerability of methotrexate and methylprednisolone in a comparative assessment of the primary and long-term outcomes in patients with pulmonary sarcoidosis","volume":"11","author":"Gavrysyuk","year":"2021","journal-title":"Diagnostics"},{"key":"10.1016\/j.rmed.2025.108126_bib20","first-page":"217","article-title":"Effectiveness and tolerability of methotrexate in pulmonary sarcoidosis: a single center real-world study","volume":"36","author":"Fang","year":"2019","journal-title":"Sarcoidosis Vasc. Diffuse Lung Dis."},{"key":"10.1016\/j.rmed.2025.108126_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.rmed.2022.107055","article-title":"Durable medication-free remission of sarcoidosis following discontinuation of anti-tumor necrosis factor-\u03b1 therapy","volume":"206","author":"Yee","year":"2023","journal-title":"Respir. Med."},{"key":"10.1016\/j.rmed.2025.108126_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010952","article-title":"Long-term corticosteroid-sparing immunosuppression for cardiac sarcoidosis","volume":"8","author":"Rosenthal","year":"2019","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.rmed.2025.108126_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.amjcard.2023.07.088","article-title":"Incidence and predictors of relapse after weaning immune suppressive therapy in cardiac sarcoidosis","volume":"204","author":"Arps","year":"2023","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.rmed.2025.108126_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1111\/j.1440-1843.2009.01518.x","article-title":"Clinical outcomes in sarcoidosis after cessation of infliximab treatment","volume":"14","author":"Panselinas","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2025.108126_bib25","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1183\/09031936.00055213","article-title":"Prediction of relapse after discontinuation of infliximab therapy in severe sarcoidosis","volume":"43","author":"Vorselaars","year":"2014","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108126_bib26","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/qjmed\/hcl038","article-title":"Presenting characteristics as predictors of duration of treatment in sarcoidosis","volume":"99","author":"Baughman","year":"2006","journal-title":"Qjm."},{"key":"10.1016\/j.rmed.2025.108126_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.04079-2020","article-title":"ERS clinical practice guidelines on treatment of sarcoidosis","volume":"58","author":"Baughman","year":"2021","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2025.108126_bib28","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1007\/s12350-022-03171-6","article-title":"Prednisone vs methotrexate in treatment na\u00efve cardiac sarcoidosis","volume":"30","author":"Vis","year":"2023","journal-title":"J. Nucl. Cardiol. : official publication of the American Society of Nuclear Cardiology"},{"key":"10.1016\/j.rmed.2025.108126_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jcmg.2023.05.017","article-title":"Prospective analysis of immunosuppressive therapy in cardiac sarcoidosis with fluorodeoxyglucose myocardial accumulation: the PRESTIGE study","volume":"17","author":"Morimoto","year":"2024","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500188X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S095461112500188X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T23:24:32Z","timestamp":1762039472000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S095461112500188X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":29,"alternative-id":["S095461112500188X"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108126","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Durable remission of cardiac sarcoidosis following discontinuation of methotrexate: A prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2025.108126","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108126"}}